Healthtech Pre-Seed Investors & VC Firms
1328 firms in this list, with a median first check of $250K. 362 of them lead rounds. Generated from verified public data and updated continuously.
Alliance VC
OsloPre-Seed–Series B
9 people
First Circle
CasablancaPre-Seed–Seed$100K – $250K
21 people
Roo Capital
New YorkPre-Seed–Series A$500K – $25M
24 people
SucSEED Indovation
HyderabadPre-Seed–Growth$4K – $1.1M
11 people
UpHonest Capital
Silicon ValleyPre-Seed–Series B$50K – $1M
20 people
Angel Bridge Co.,Ltd.
TokyoPre-Seed–Growth$792K – $62M
9 people
Boutique Venture Partners
Palo AltoPre-Seed–Series A
21 people
ICI
Fort CollinsPre-Seed–Seed
29 people
BdsVC
MumbaiPre-Seed–Series A$300K – $5M
21 people
Voima Ventures
HelsinkiPre-Seed–Series B$216K – $3.2M
12 people
MassChallenge Mexico
BostonPre-Seed–Growth
29 people
Coral Capital
TokyoPre-Seed–Growth$1M – $184M
2 people
ACME Capital
San FranciscoPre-Seed–Growth
12 people
Reshape
New YorkPre-Seed–Late Stage
1 person
Halcyon
WashingtonPre-Seed–Seed
28 people
QVentures
LondonPre-Seed–Late Stage$127K – $6.3M
10 people
Stout Street Capital
DenverPre-Seed–Series B$250K
4 people
BioGenerator Ventures
St. LouisPre-Seed–Series B$50K – $250K
23 people
Hyde Park Angels
ChicagoPre-Seed–Growth
5 people
AdBio partners
ParisPre-Seed–Series A
21 people
Innovobot
MontrealPre-Seed–Series A$182.5K – $365K
30 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
27 people
Brinc
Hong KongPre-Seed–Seed$100K – $500K
Capital Factory
AustinPre-Seed–Series A
12 people
Related lists
Pre-Seed Investors & VC Firms (5679)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Pre-Seed Investors & VC Firms in United States (2090)AI & Machine Learning Pre-Seed Investors & VC Firms (1855)Healthtech Investors & VC Firms in United States (1616)SaaS Pre-Seed Investors & VC Firms (1575)Pre-Seed Investors & VC Firms in Global (1485)Fintech Pre-Seed Investors & VC Firms (1477)
Data sourced from public filings and firms' own websites — see our methodology.





































































